Palle Christophersen
Founder presso SANA AB
Patrimonio netto: 157 694 $ in data 31/03/2024
Profilo
Palle Christophersen is the founder of Saniona AB, which was founded in 2011.
He holds the title of Executive Vice President-Research at Saniona AB.
Dr. Christophersen is currently the Chief Scientific Officer at Saniona A.
Dr. Christophersen previously worked at NTG Nordic Transport Group A from 1991 to 2012, where he held the title of Vice President & Director-Vitro Pharmacology.
Dr. Christophersen obtained a doctorate degree from the University of Copenhagen.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SANIONA AB
0.79% | 31/12/2022 | 874 571 ( 0.79% ) | 157 694 $ | 31/03/2024 |
Posizioni attive di Palle Christophersen
Società | Posizione | Inizio |
---|---|---|
SANA AB | Founder | 01/01/2011 |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Palle Christophersen
Società | Posizione | Fine |
---|---|---|
NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 01/01/2012 |
Formazione di Palle Christophersen
University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
SANA AB | Health Technology |
Aziende private | 1 |
---|---|
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Commercial Services |
- Borsa valori
- Insiders
- Palle Christophersen